←
Barry Singer MD 🧠3,411 posts
Barry Singer MD 🧠 avatar

Barry Singer MD 🧠

@drbarrysinger

Director, MS Center for Innovations in Care. 🧠 doctor helping people live well with multiple sclerosis. Podcast host: apple.co/3mwg1Mo Tweets ≠ medical advice

◷ Joined May 2013▧ 945 Photos and videos
Barry Singer MD 🧠 avatar
Barry Singer MD 🧠@drbarrysinger·Oct 23

Oh: Phase 3 fenebrutinib reduced slowly expanding lesion (SEL) counts by 21.5% vs ocrelizumab in PPMS and 18.3% vs teriflunomide in RMS. SEL volumes reduced 27.5% and 30.5%, respectively. Fewer patients on fenebrutinib accumulated PRLs. #MSTORONTO2026

Post attachmentPost attachmentPost attachmentPost attachment
Barry Singer MD 🧠 avatar
Barry Singer MD 🧠@drbarrysinger·Oct 23

Ontaneda: First Phase 1 results of off-the-shelf CD19 CAR T-cell therapy (azer-cel) in progressive MS (n=26). No dose-limiting toxicities; EDSS stable/improved in 16/18 at Day 90. Early data; follow-up ongoing. #MSTORONTO2026

Post attachmentPost attachmentPost attachmentPost attachment
Barry Singer MD 🧠 avatar
Barry Singer MD 🧠@drbarrysinger·Oct 22

Varjú: Danish #MS registry shows a dramatic shift in switch from escalation strategy to early use of high efficacy treatment. No difference in PIRA outcomes between these approaches. 🤔 Controlling for all variables seems challenging…. #MSTORONTO2026

Post attachmentPost attachmentPost attachmentPost attachment
Barry Singer MD 🧠 avatar
Barry Singer MD 🧠@drbarrysinger·Oct 22

Sormani: Pooled FENhance 1 and 2 RMS. Fenebrutinib compared to teriflunomide ⬇️relapses 55%, ⬇️ enhancing lesions 75% and ⬇️ new/enlarging T2 80%. Composite disability results below. #MSTORONTO2026

Post attachmentPost attachmentPost attachmentPost attachment